Chefs' Warehouse, Inc.: Form 10-Q for the period ended Mar 28, 2025
Filed with the SEC on Apr 30, 2025 and accepted by EDGAR at Apr 30, 2025, 09:28 ET.
Management's discussion and analysis
As filed, 9,647 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided as a supplement to the accompanying condensed consolidated financial statements and footnotes to help provide an understanding of our financial condition, changes in our financial condition and results of operations. The following discussion should be read in conjunction with information included in our Annual Report on Form 10-K for the fiscal year ended December 27, 2024 (the “2024 Form 10-K”) filed with the SEC. Unless otherwise indicated, the terms “Company”, “Chefs’ Warehouse”, “we”, “us” and “our” refer to The Chefs’ Warehouse, Inc. and its subsidiaries. All dollar amounts included in the tables in the following discussion are presented in thousands.
Business Overview
We are a premier distributor of specialty foods in the leading culinary markets in the United States, the Middle East and Canada. We offer more than 88,000 stock-keeping units (“SKUs”), ranging from high-quality specialty foods and ingredients to basic ingredients and staples and center-of-the-plate proteins. We serve more than 50,000 core customer locations, primarily located in our 23 geographic markets across the United States, the Middle East and Canada, and the majority of our customers are independent restaurants and fine dining establishments. We also sell certain of our center-of-the-plate products directly to consumers through our Allen Brothers subsidiary.
RESULTS OF OPERATIONS
| Thirteen Weeks Ended March 28, 2025 | March 29, 2024 | |
|---|---|---|
| Net sales | $950,748 | $874,488 |
| Cost of sales | 724,753 | 665,052 |
| Gross profit | 225,995 | 209,436 |
| Selling, general and administrative expenses | 202,763 | 190,321 |
| Other operating expenses, net | 497 | 3,112 |
| Operating income | 22,735 | 16,003 |
| Interest expense | 10,253 | 13,244 |
| Income before income taxes | 12,482 | 2,759 |
| Provision for income tax expense | 2,194 | 828 |
| Net income | $10,288 | $1,931 |
15
Thirteen Weeks Ended March 28, 2025 Compared to Thirteen Weeks Ended March 29, 2024
Net Sales
| 2025 | 2024 | $ Change | % Change | |
|---|---|---|---|---|
| Net sales | $950,748 | $874,488 | $76,260 | 8.7% |
Net sales increased due to organic growth as there was no impact from acquisitions. Case count increased approximately 5.7% in our specialty category. In addition, unique customers and placements in our specialty category increased 4.5% and 7.7%, respectively, compared to the prior year period. Pounds sold in our center-of-the-plate category decreased 1.3% compared to the prior year. Estimated inflation was 4.8% in our specialty category and 5.9% in our center-of-the-plate category compared to the prior year period.
Gross Profit
| 2025 | 2024 | $ Change | % Change | |
|---|---|---|---|---|
| Gross profit | $225,995 | $209,436 | $16,559 | 7.9% |
| Gross profit margin | 23.8% | 23.9% |
Gross profit dollars increased primarily as a result of increased sales and price inflation. Gross profit margin decreased approximately 18 basis points. Gross profit margins increased 6 basis points in the Company’s specialty category and decreased 83 basis points in the Company’s center-of-the-plate category.
Selling, General and Administrative Expenses
| 2025 | 2024 | $ Change | % Change | |
|---|---|---|---|---|
| Selling, general and administrative expenses | $202,763 | $190,321 | $12,442 | 6.5% |
| Percentage of net sales | 21.3% | 21.8% |
The increase in selling, general and administrative expenses was primarily due to higher costs associated with compensation and benefits, facilities and distribution to support sales growth and higher depreciation expense driven by facility investments. Our ratio of selling, general and administrative expenses to net sales decreased 50 basis points due to sales growth combined with certain benefits derived from our investments in our facility and distribution operations.
Other Operating Expenses, Net
| 2025 | 2024 | $ Change | % Change | |
|---|---|---|---|---|
| Other operating expenses, net | $497 | $3,112 | $(2,615) | (84.0)% |
Other operating expenses, net decreased by $2.6 million primarily due to lower employee severance charges incurred in the current quarter compared to the prior year quarter.
Interest Expense
| 2025 | 2024 | $ Change | % Change | |
|---|---|---|---|---|
| Interest expense | $10,253 | $13,244 | $(2,991) | (22.6)% |
Interest expense decreased primarily due to lower aggregate principal amounts of debt outstanding and lower interest rates in the current quarter compared to the prior year quarter.
Provision for Income Tax Expense
| 2025 | 2024 | $ Change | % Change | |
|---|---|---|---|---|
| Provision for income tax expense | $2,194 | $828 | $1,366 | 165.0% |
| Effective tax rate | 17.6% | 30.0% |
The Company’s effective tax rate was 17.6% and 30.0% for the thirteen weeks ended March 28, 2025 and March 29, 2024, respectively. The effective tax rate for the thirteen weeks ended March 28, 2025 reflects the annual effective tax rate estimated for the full fiscal year, adjusted for a discrete item related to a tax benefit from the vesting of stock awards during the period.
LIQUIDITY AND CAPITAL RESOURCES
We finance our day-to-day operations and growth primarily with cash flows from operations, borrowings under our senior secured credit facilities and other indebtedness, operating leases, trade payables and equity financing.
Indebtedness
The following table presents selected financial information on our indebtedness:
| March 28, 2025 | December 27, 2024 | |
|---|---|---|
| Senior secured term loan | $259,250 | $260,000 |
| Convertible senior notes | 287,500 | 287,500 |
| Borrowings outstanding on asset-based loan facility | 100,000 | 120,000 |
| Finance leases and other financing obligations | 67,583 | 52,673 |
Financing Transactions
During the thirteen weeks ended March 29, 2024, we made voluntary principal prepayments of $6.0 million towards the senior secured term loan.
In November 2023, we announced a two-year share repurchase program in an amount up to $100.0 million, targeting $25.0 million to $100.0 million of share repurchases by the end of fiscal 2025. During the thirteen weeks ended March 29, 2024, we repurchased 134,553 shares of our common stock at an average purchase price of $37.16 per share. The share repurchases were funded by our available cash. There were no share repurchases during the thirteen weeks ended March 28, 2025. The remaining share purchase authorization was $82.6 million at March 28, 2025. We are not obligated to repurchase any specific number of shares and may suspend or discontinue the program at any time.
Liquidity
The following table presents selected financial information on liquidity:
| March 28, 2025 | December 27, 2024 | |
|---|---|---|
| Cash and cash equivalents | $116,530 | $114,655 |
| Working capital(1), excluding cash and cash equivalents | 311,226 | 327,992 |
| Availability under asset-based loan facility | 162,425 | 146,674 |
(1) We define working capital as current assets less current liabilities.
We expect our capital expenditures, excluding cash paid for acquisitions, for fiscal 2025 will be approximately $40.0 million to $50.0 million. We believe our existing balances of cash and cash equivalents, working capital and the availability under our asset-based loan facility, are sufficient to satisfy our working capital needs, capital expenditures, debt service and other liquidity requirements associated with our current operations over the next twelve months.
Cash Flows
The following table presents selected financial information on cash flows:
| Thirteen Weeks Ended March 28, 2025 | March 29, 2024 | |
|---|---|---|
| Net cash provided by operating activities | $49,566 | $30,900 |
| Net cash used in investing activities | (12,344) | (17,381) |
| Net cash used in financing activities | (35,412) | (21,252) |
Our cash provided by operating activities is predominately driven by net sales to our customers. Our cash used in operating activities is primarily driven by our payments to suppliers for our inventory, employee compensation, payments to support our facilities, our distribution network, interest on our indebtedness, payments to tax authorities and other general corporate expenditures. Net cash provided by operations was $49.6 million for the thirteen weeks ended March 28, 2025 compared to $30.9 million for the thirteen weeks ended March 29, 2024. The increase in cash provided by operating activities was primarily due to sales growth, lower cash paid for interest, lower other operating expenses and improvements in working capital management.
Net cash used in investing activities was $12.3 million for the thirteen weeks ended March 28, 2025, driven by capital expenditures.
Net cash used in financing activities was $35.4 million for the thirteen weeks ended March 28, 2025 driven by $20.0 million of payments under our revolving credit facilities, $11.4 million paid for shares surrendered to pay tax withholding related to the vesting of equity incentive plan awards, $3.3 million of finance lease payments and $0.8 million of payments of term loan debt.
Recent Accounting Pronouncements
Information related to new accounting guidance is included in Note 1 “Operations and Basis of Presentation” to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
Market risk
As filed, 389 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Interest Rate Risk
Our exposure to interest rate market risk relates primarily to our long-term debt. As of March 28, 2025, we had aggregate indebtedness outstanding of $359.3 million that bore interest at variable rates. A 100 basis point increase in market interest rates would decrease our after-tax earnings by approximately $2.6 million per annum, holding other variables constant.
Controls and procedures
As filed, 959 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective as of March 28, 2025.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the quarter ended March 28, 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 311 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to our risk factors as previously disclosed in Part I, Item 1A. included in our Annual Report on Form 10-K for the year ended December 27, 2024. In addition to the information contained herein, you should consider the risk factors disclosed in our Annual Report on Form 10-K.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-12-28 to 2025-03-28 | $950.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-12-28 to 2025-03-28 | $724.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-12-28 to 2025-03-28 | $226.0m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-12-28 to 2025-03-28 | $202.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-12-28 to 2025-03-28 | $22.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-12-28 to 2025-03-28 | $10.3m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2024-12-28 to 2025-03-28 | $2.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-12-28 to 2025-03-28 | $10.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-12-28 to 2025-03-28 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-12-28 to 2025-03-28 | $0.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-12-28 to 2025-03-28 | 46,091,441 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-12-28 to 2025-03-28 | $49.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-12-28 to 2025-03-28 | $12.3m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 3 months2024-12-28 to 2025-03-28 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-03-28 | $116.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-28 | $835.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-28 | $1.84bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-28 | $407.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-28 | $1.30bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-03-28 | $681.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-03-28 | $20.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-03-28 | $541.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001517175-25-000008. Last ingested by Listed: Nov 15, 2026, 01:17 ET. Listed shows no prices and gives no investment advice.